Do Pharmacies Need a WDA? (2026)

What Pharmacies Need to Know Now About WDA(H): A Full Guide for 2026

Supply chains in pharmacies have tightened significantly since the days of the “5% rule.” If you’re a pharmacy owner, superintendent pharmacist, or part of a hospital or community pharmacy, it’s essential to know whether your operational activities may trigger the need for a Wholesaler Distribution Authorisation aka WDA(H), and what that means in practice, both operationally and financially.

This blog updates the 2016 Paradigm Shift blog in line with MHRA guidance as of mid-2025.

Why the Change, and What the Law Requires

Historically, pharmacies relied on section 10(7) of the Medicines Act 1968 to exempt small amounts of wholesale dealing (up to 5% of total turnover). That exemption was repealed under the Human Medicines Regulations 2012 (as amended). Since then, wholesale dealing of medicinal products on a commercial basis requires a valid WDA(H).

As of now, the requirement is that any pharmacy that supplies to patients indirectly, i.e. supplies other pharmacies, GP surgeries, clinics, hospitals, or any entity other than the end patient, will most likely need to be in possession of a valid WDA(H) for their site(s). Even “borrowing” or “mutual aid” is only permitted under tightly constrained, non-commercial, occasional, not-for-profit criteria.

Do I need a WDA (H)?

Good question! Whether or not you require a WDA (H) depends entirely on your pharmacy business model, it is strongly recommended that you refer to MHRA Guidance Note 6 for further information on when a WDA (H) is required and notes on how to apply for such a licence.

However, below is a simplified summary of who needs a WDA (H):

• WDA (H) Needed: Any person or organisation engaged in wholesale distribution of human medicinal products. That includes pharmacies that are importing, exporting, holding, supplying or selling medicines to persons other than the final patient. This includes requisitions from hospitals, clinics, dentists, chiropodists, district nurses, podiatrists or other HCPs. Dispensing individual named patients items against a prescription is not wholesaling. N.B. You cannot supply product and adhere labels directly to the pack for HCPs to sign and dispense, this is a manufacturing activity and would require an Manufacturing licence (MIA).Virtual pharmacies count as well. If you just sell and/or dispense to the public in a pharmacy setting, you may not need a WDA (H), but as soon as you sell to other healthcare organisations, or supply in bulk, you do.

 

• WDA (H) Not Needed (Exemptions and Limited Supplies): There are some circumstances where supply may be made without a WDA(H) for an occasional, small supply intended solely for an individual patient, made not-for-profit. But this is not a route to ongoing wholesale business. See the MHRA Guidance for pharmacists on the repeal of Section 10(7) of the Medicines Act 1968 for more information.

The Application Process

Here’s what pharmacies should expect when applying for a WDA(H):

1. Pre-application & Readiness
   Before applying, ensure your site is inspection ready, see our “MHRA inspection ready” blog for more information.
2. Using the PCL Portal
   Applications (new licence, variations) go through MHRA’s Process Licensing Portal.
3. Inspection
   MHRA will inspect the premises as part of the licensing process, verifying compliance with GDP. After your licence is granted, there will be periodic risk-based inspections, the first typically being 9-15 months after approval to confirm that you have been following the implemented procedures and required quality activities. If a variation to your licence requires new or altered activities, a further inspection may be triggered.

Decision & Conditions

The regulator may grant you a licence as requested, refuse to grant, or grant with variation or restrictions. In the event of critical findings (Unfit RP, or wholly unsuitable Quality Management System) you’ll be notified, and there an opportunity to respond will be given. The timeline for response is typically 28 days, however with critical findings this may be 14 days.

Costs & Fees for Pharmacies: What You’ll Pay

One of the most-asked questions is: “How much does this all cost?”

There is no simple answer to this question. The fees depend on many factors, including:

• whether you are applying for a full licence or a reduced licence.
• whether inspection is standard or reduced (e.g. “GSL only” sites).
• how many sites or premises are involved, and the product types/facilities (cold chain, controlled substances, unlicensed medicines, medical cannabis etc).
• whether the pharmacy is a “reduced” case (less wholesale activity) or otherwise meets certain lower thresholds (Note that we may be able to save you half on your licence if you are GSL only, or pharmacy with a smaller proposed turnover).

In addition, annual service/maintenance fees are payable to keep the licence active. These are invoiced in April each year. The amount depends on the licence.

For more information relating to costs and fees, please refer to our “The Real costs of a WDA” blog post.

Risks and Common Deficiencies relating to Pharmacy WDAs

• Supplying “wholesale” to another body without WDA(H) risks referral to the GPhC. The MHRA and GPhC have a Memorandum of Understanding. Illegal medicinal supply could become a fitness to practice matter!!
• Appointing a Responsible Person who lacks required experience in the role of a RP, the management of a Pharmaceutical Quality Management System (PQMS) or the knowledge and understanding of National law and GDP Guidelines, leading to rejection of your application, or potential removal of the RP and suspension of the licence.
• Premises, cold-chain storage, transport validation, quality management gaps feature frequently in MHRA inspector deficiency findings.
• Sometimes pharmacies think “if it’s small” they don’t need WDA(H), however, any repeated supply to another pharmacy or clinic or operation resembling business‐to‐business trade is likely to trigger the requirement to hold a WDA(H).

Paradigm Shift Consultants: Common Findings Relating to Pharmacies

• Many pharmacies we are asked to consult for are currently operating in a grey area without realising they need a full WDA(H), especially if they supply even small regular quantities to clinics or other pharmacies.
• Some think they are exempt from the WDA(H) requirement because “they only do a few packs occasionally”.  The MHRA has made it clear that what matters is frequency, profit and commercial nature, who the recipient is and the value of the sales.
• Financial and time costs for obtaining a WDA(H) have risen, and preparing for inspection (premises, temperature mapping, documentation) takes effort. We tend to anticipate a supported bedding-in period of several months to facilitate gap analysis, implementation of the Quality Management System, then submit the formal application, inspection etc.
• MHRA inspection findings can be costly to remediate and could result in the rejection of a licence application or a suspension or revocation of an issued WDA(H).

What Pharmacies Should Do Now

If you suspect your operations need WDA(H), here’s a step-by-step for getting compliant:

1. Review your current distribution activity to determine whether you are suppling other pharmacies, clinics or hospitals.
• If so, check whether the supply exceeds the MHRA occasional, small or non-profit thresholds – the MHRA expectation for this is no more than a handful of packs across the year.
2. Appoint or verify your Responsible Person – we can support with an RP assessment – a “Gold Standard” certificate means very little, experience at a similar site with good inspection results is common sense! Even someone with basic knowledge could convince you they know what they are doing, and this might cost you dearly.
   
3. Prepare your quality management system, premises and operational activities – this is our bread and butter!
4. Submit application via MHRA’s PCL Portal – We are portal super users and can assist.
5. Ensure you are ‘Inspection Ready’ at all times – proper resourcing with sufficient competent personnel… which is unlikely in most new applications.

Stay compliant with HMR 2012 and EU GDP Guidelines after licence granted!

Summary

• The 5% rule? It’s gone! If you are dealing in wholesale in any organisation business sense, you almost certainly need a WDA(H).
• It’s not just about cost, it is about establishing proper systems, ensuring compliance, having a RP in place etc. The legal, patient-safety and reputational risks are real.
• Planning ahead pays off, get your paperwork, premises, RP, and quality systems ready BEFORE application so that inspection goes smoothly.
• Engage with experienced consultants, consultancies such as Paradigm Shift are highly experienced with assisting pharmacies with the regulatory requirement of applying for, varying and maintaining a WDA(H) and can support you on your journey compliantly.
• We always offer a free initial consultation, whether you choose us or not, make the wise decision of understanding the situation BEFORE you commit to premises, personnel or a new van!

If you want help assessing whether your pharmacy needs a WDA(H) or estimating costs/timelines specific to your business model, Paradigm Shift Consulting can run a custom audit and gap assessment. Just get in touch.